Medical Devices Switzerland

Switzerland Cardiovascular Devices Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Switzerland Cardiovascular Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Switzerland · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $738.5 Mn Placeholder estimate
Estimate 2025 $781.3 Mn 1.2% of the global market
Projected 2034 $1.30 Bn 66.1% Adds $516.5 Mn over 9 forecast years
CAGR 2025–2034 5.8% Faster than 50% of 6 Medical Devices markets here
Key players 6 +1
  • Switzerland is 1.18% of the global market.
  • In Europe, the largest is Germany at $2.46 Bn.
  • Fastest growing: Italy at 6.8% a year.
  • Switzerland ranks 7th of 13 by size in Europe.

Market size projection

Switzerland

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$516.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Cardiovascular Devices Market market size by year, Switzerland
YearMarket sizeChange that yearSince 2025
2024 (estimate) $738.5 Mn — —
2025 (base) $781.3 Mn +$42.8 Mn —
2026 (forecast) $826.6 Mn +$45.3 Mn +5.8%
2027 (forecast) $874.6 Mn +$47.9 Mn +11.9%
2028 (forecast) $925.3 Mn +$50.7 Mn +18.4%
2029 (forecast) $979.0 Mn +$53.7 Mn +25.3%
2030 (forecast) $1.04 Bn +$56.8 Mn +32.6%
2031 (forecast) $1.10 Bn +$60.1 Mn +40.3%
2032 (forecast) $1.16 Bn +$63.6 Mn +48.4%
2033 (forecast) $1.23 Bn +$67.2 Mn +57%
2034 (forecast) $1.30 Bn +$71.1 Mn +66.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Switzerland Cardiovascular Devices Market Analysis at a glance
Market size, 2025$781.3 Mn placeholder estimate
Forecast, 2034$1.30 Bn placeholder estimate
Growth (CAGR), 2025–20345.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersMedtronic, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Johnson & Johnson and 1 more (see all)
Regulator in SwitzerlandSwissmedicSource: Swissmedic. Checked 19 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Switzerland Cardiovascular Devices Market Analysis Executive Summary

Cardiovascular devices diagnose, monitor and treat heart and blood vessel disease, from stents and valves to pacemakers.

Key segments of the cardiovascular devices market include product (Stents, Heart Valves and Pacemakers and Defibrillators) and application (Coronary Artery Disease, Arrhythmia and Heart Failure).

Bar chart: Switzerland Cardiovascular Devices market size, 2024–2034, placeholder estimates. $738.5 Mn in 2024, $781.3 Mn in 2025 and $1.30 Bn in 2034, 5.8% CAGR.
Switzerland Cardiovascular Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Switzerland Cardiovascular Devices Market Dynamics

Market Growth Drivers

An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the cardiovascular devices market.

Opportunity

Smart implants, less invasive techniques and growing access to surgery in emerging economies give the cardiovascular devices market room to grow.

Market Restraints

Strict approval rules, price pressure from hospital buyers and shortages of trained surgeons in some regions hold back the cardiovascular devices market.

Competitive Landscape for Cardiovascular Devices Market in Switzerland

The cardiovascular devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Cardiovascular Devices Market in Switzerland

Cardiovascular Devices in Switzerland: rules and payment

Medical devices need a conformity assessment under Swiss rules that closely follow the EU Medical Device Regulation, and Swissmedic oversees them.⁠[1] Everyone must buy basic health insurance from an approved insurer, and the Federal Office of Public Health (FOPH) decides which medicines it pays for.⁠[2]

[1] Swissmedic. Checked 19 Nov 2026.

[2] Federal Office of Public Health (FOPH). Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how cardiovascular devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Switzerland.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Cardiovascular Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Cardiovascular Devices in context

Switzerland compared

  • Health spending per person: 11,784 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 13 countries we cover in Europe.[1]
  • Doctors: 4.48 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 13 countries we cover in Europe.[2]
  • People aged 65 and over: 20.4% of people (2025). World: 10.4% of people (2025). 10th highest of the 13 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Cardiovascular Devices market in Switzerland?
Placeholder estimate: about $781.3 Mn in 2025, rising to about $1.30 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Cardiovascular Devices market in Switzerland growing?
Placeholder estimate: about 5.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Cardiovascular Devices market report cover?
The report splits the market by product (Stents, Heart Valves, Pacemakers and Defibrillators, Catheters and more), application (Coronary Artery Disease, Arrhythmia, Heart Failure, Structural Heart Disease) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Cardiovascular Devices market?
Key players include Medtronic, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Johnson & Johnson and Biotronik SE & Co. KG.
What is driving the Cardiovascular Devices market?
An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the cardiovascular devices market.
Who regulates Cardiovascular Devices in Switzerland?
Medical devices need a conformity assessment under Swiss rules that closely follow the EU Medical Device Regulation, and Swissmedic oversees them. Source: Swissmedic. Checked 19 Nov 2026.
How is healthcare paid for in Switzerland?
Everyone must buy basic health insurance from an approved insurer, and the Federal Office of Public Health (FOPH) decides which medicines it pays for. Source: Federal Office of Public Health (FOPH). Checked 19 Nov 2026.
How much research is published on Cardiovascular Devices?
PubMed lists 181 papers on Cardiovascular Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 20 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Switzerland

See all

Related on cardiovascular

See the topic